Download presentation
Presentation is loading. Please wait.
1
NON-SMALL CELL LUNG CANCER 2011-2015
Prepared by Theresa SanLorenzo-Caswell,CTR 11/14/2016
2
NON-SMALL CELL & small cell LUNG CANCER 2011-2015
Prepared by Theresa SanLorenzo-Caswell,CTR 11/14/2016
3
NON-SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 1926 ANALYTIC vs
NON-SMALL CELL LUNG CANCER ALL CASES = 1926 ANALYTIC vs. NON-ANALYTIC
4
NON-SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 1926 AGE OF DIAGNOSIS BY GENDER
5
NON-SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 1926 GENDER BY YEAR
6
NON-SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 1926 RACE BY GENDER
7
NON-SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 1926 STATE OF RESIDENCE AT DIAGNOSIS
8
NON-SMALL CELL LUNG CANCER 2011-2015 ALL MARYLAND CASES = 1394 COUNTY OF RESIDENCE AT DIAGNOSIS
9
NON-SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 1926 BY HISTOLOGY
10
NON-SMALL CELL LUNG CANCER 2011-2015 ANALYTIC CASES
NON-SMALL CELL LUNG CANCER ANALYTIC CASES* = 1558 BY AJCC STAGE *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere
11
NON-SMALL CELL LUNG CANCER 2011-2015 ANALYTIC CASES
NON-SMALL CELL LUNG CANCER ANALYTIC CASES* = 1558 AJCC STAGE BY GENDER *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere
12
NON-SMALL CELL LUNG CANCER 2011-2015 ANALYTIC CASES
NON-SMALL CELL LUNG CANCER ANALYTIC CASES* = 1547 AJCC STAGE BY GENDER AJCC I AJCC II AJCC III AJCC IV AJCC UNK SURGERY ONLY 77.5% 37.2% 3.9% 3.0% 20.0% RADIATION ONLY 13.2% 2.9% 4.7% 16.4% CHEMOTHERAPY ONLY 1.1% 9.5% 19.8% SURGERY & RADIATION 0.6% 1.2% 1.4% SURGERY & CHEMOTHERAPY 3.1% 34.9% 10.6% 2.4% RADIATION & CHEMOTHERAPY 1.5% 7.6% 39.6% 35.3% SURGERY, RADIATION & CHEMOTHERAPY 9.9% 21.4% 4.3% OTHER COMBINATIONS 1.7% 2.8% 4.9% NO TREATMENT 6.1% 13.3% 40.0% 100% Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere
13
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
14
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
15
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
16
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
NON-SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
17
SMALL CELL LUNG CANCER 2011-2015
18
SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 231 ANALYTIC vs
SMALL CELL LUNG CANCER ALL CASES = 231 ANALYTIC vs. NON-ANALYTIC
19
SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 231 AGE OF DIAGNOSIS BY GENDER
20
SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 231 GENDER BY YEAR
21
SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 231 RACE BY GENDER
22
SMALL CELL LUNG CANCER 2011-2015 ALL CASES = 231 STATE OF RESIDENCE AT DIAGNOSIS
23
SMALL CELL LUNG CANCER 2011-2015 ALL MARYLAND CASES = 179 COUNTY OF RESIDENCE AT DIAGNOSIS
24
SMALL CELL LUNG CANCER 2011-2015 ANALTYIC CASES
SMALL CELL LUNG CANCER ANALTYIC CASES* = 181 AJCC STAGE AT DIAGNOSIS *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere
25
SMALL CELL LUNG CANCER 2011-2015 ANALYTIC CASES
SMALL CELL LUNG CANCER ANALYTIC CASES* = 181 AJCC STAGE BY GENDER *Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere
26
SMALL CELL LUNG CANCER 2011-2015 ANALYTIC CASES
SMALL CELL LUNG CANCER ANALYTIC CASES* = 181 AJCC STAGE BY GENDER AJCC I AJCC II AJCC III AJCC IV AJCC UNK CHEMOTHERAPY ONLY 12.5% 7.14% 14.9% 30.6% RADIATION ONLY 2.1% 6.3% SURGERY & CHEMOTHERAPY 25.0% 14.3% 0.9% RADIATION & CHEMOTHERAPY 37.5% 50.0% 76.6% 46.0% 100.0% OTHER COMBINATIONS 21.5% 4.5% SURGERY, RADIATION & CHEMOTHERAPY 4.3% 1.8% NO TREATMENT 9.9% 100% Excludes Class 0: Diagnosed at JHH only; all treatment elsewhere
27
SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
28
SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
29
SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
30
SMALL CELL LUNG CANCER OBSERVED SURVIVAL 2003-2009 JHH vs. NCDB vs
SMALL CELL LUNG CANCER OBSERVED SURVIVAL JHH vs. NCDB vs. SEER ©2016 NCDB, CoC *(NCDB SURVIVAL RESULTS CAN NOT BE PUBLICLY SHARED ©SEER; SEER*STAT
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.